Home
Pre-Filled Syringes
28 January - 29 January 2013
Pre-Filled Syringes

After the overwhelming success of our 2012 conference, SAE Media Group are proud to present Europe's leading Pre-Filled Syringes event. Building on the success of our previous event, this 5th annual event promises to be bigger and better! This exciting event will present itself as a perfect forum for learning about new advances in the field, providing attendees with the latest information on technological and regulatory updates from key industry professionals. 

The 2013 event will include senior industry representatives presenting on their own experiences and referring to case studies, success stories and failures, this event promises to be a unique forum for problem-solving debate and idea-sharing discussion.

With a reputation for attracting the industry's leading figures, this year's forum will look at key areas including device development and the design concept; secondary packaging and quality assurance; site design and regulation and will provide essential advice on how to create strategies for future commercial success. Providing an in-depth market overview, whilst delivering insightful looks into regulatory considerations, formulations and sterilization; this year's event promises to be an unmissable event!
 

FEATURED SPEAKERS

Advait Badkar PhD.

Advait Badkar PhD.

Associate Research Fellow- Technology Lead, Pfizer Inc
Patrick Garidel

Patrick Garidel

Head of Pharmaceutical Basic Development, Boehringer Ingelheim Corporation

Advait Badkar PhD.

Associate Research Fellow- Technology Lead, Pfizer Inc
Advait Badkar PhD.

Alexander Jaksch

VP Business Development & Marketing, Safety Syringes
Alexander Jaksch

Anil-Kumar Busimi

Product Manager, SCHOTT AG
Anil-Kumar Busimi

Carsten Worsoe

Principal Scientist, Novo Nordisk
Carsten Worsoe

Dale Charlton

Business Development Director, Optima Pharma
Dale Charlton

Dan Wheeler

Lecturer in Anaesthesia, University of Cambridge
Dan Wheeler

Daniel Bar-Shalom

Associate Professor, University of Copenhagen
Daniel Bar-Shalom

David Whitaker

Consultant Anaesthetist, Manchester Royal Infirmary
David Whitaker

Dragana Cvijanovic

Product Manager, BD Medical - Pharmaceutical
Dragana Cvijanovic

Frank Janssen

Global Key Account Manager, Schreiner MediPharm
Frank Janssen

Jasdeep Singh

Head of PMU, Barts and the London NHS Trust
Jasdeep Singh

Martin Bontoft

Head of Design Research, Team Consulting
Martin Bontoft

Mathias Misiek

Group Leader, Clinical Manufacturing, Roche Pharmaceuticals
Mathias Misiek

Morag Bratby

Pharmaceutical Assessor, MHRA
Morag Bratby

Nicolas Brandes

Manager CZ European Business Development, West Pharmaceutical Services
Nicolas Brandes

Nicolas Morais

Product Manager, BD Medical - Pharmaceutical
Nicolas Morais

Oliver K. Valet

Managing director, rap.ID Particle Systems GmbH
Oliver K. Valet

Patrick Garidel

Head of Pharmaceutical Basic Development, Boehringer Ingelheim Corporation
Patrick Garidel

Richard Hart

Pharma Partner Executive, Baxter
Richard  Hart

Sergej Toedtli

CEO, Vesdo Ltd
Sergej Toedtli

Stephen Barat

Senior Director, Toxicology and Operations, Forest Laboratories
Stephen Barat

Violeta Gabrijelcic

Head Global Pharmaceutical & Device Development, Sandoz
Violeta Gabrijelcic

Conference agenda

clock

8:30

Registration and Coffee

clock

9:00

Welcome and Introductions

clock

9:15

The landscape and current trends in self-injection

clock

9:45

How to 'do' human factors engineering in line with regulatory requirements

clock

10:15

Beyond validation: desirability, advocacy, adherence

clock

10:45

Mindsets and methodologies for researching the patient experience

clock

11:15

Morning Coffee

clock

11:30

The customer journey: the path to participation

clock

12:00

What constraints have we imposed on our user appeal aspirations by the technology we've selected

clock

12:30

Close of Workshop

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Advait Badkar PhD.

Advait Badkar PhD., Associate Research Fellow- Technology Lead, Pfizer Inc

clock

9:10

Pre-filled syringe developments for biotechs

Nicolas Morais

Nicolas Morais, Product Manager, BD Medical - Pharmaceutical

• Prefilled syringe market overview
• Patient, regulatory and operational excellence trends for the biotech
• Injectable market
• Development of new biotech prefillable systems answering unmet needs

clock

9:50

Development considerations for biologics as pre-filled syringe products: A QbD approach

Advait Badkar PhD.

Advait Badkar PhD., Associate Research Fellow- Technology Lead, Pfizer Inc

• Quality Attributes for Pre-filled syringe products that are of concern
• Component Selection and Risk Assessment
• Co-development with Component Manufacture
• Taking these lessons and making immediate improvements

clock

10:30

Morning Coffee

clock

11:00

Development of pre-filled syringes for high concentrated liquid protein formulations

Patrick Garidel

Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim Corporation

• Challenges for the development of HCLF biologics
• Interactions with primary packaging
• Stability issues
• Medical requirements and application

clock

11:40

Extractables and Leachable investigations and documentation for pre-filled syringes

Carsten Worsoe

Carsten Worsoe, Principal Scientist, Novo Nordisk

• Risk assessment for extractables and leachabes in PFS
• Optimal study for PFS - extractable, simulated or leachable study ?
• Experiences with glass vs. plastic PFS
• Case studies on extractables and leachables in PFS systems

clock

12:20

Networking Lunch

clock

13:40

Formulation and Pre-filled Syringe Development for Biosimilars - Sandoz Experience

Violeta Gabrijelcic

Violeta Gabrijelcic, Head Global Pharmaceutical & Device Development, Sandoz

clock

14:15

Safety Assessment of Leachables from Container Closure Systems – Pre-Filled Syringes

Stephen Barat

Stephen Barat, Senior Director, Toxicology and Operations, Forest Laboratories

•    Overview of the needs for safety evaluation of leachables
•    Outline of the approaches taken for toxicological assessment of leachables
•    Considerations to take during development
•    Working examples of safety assessments for pre-filled syringe drug products 

clock

14:40

Daikyo Crystal Zenith® Prefillable syringe Systems: A Superior Containment Alternative over Glass Syringes

Nicolas Brandes

Nicolas Brandes, Manager CZ European Business Development, West Pharmaceutical Services

• The unique properties of Daikyo Crystal Zentih prefillable syringe systems
• Discussion into the associated processing requirements to fill and finish these unique systems
• Exponential advantages for the safety and stability of high value biopharmaceutical drug products

clock

15:20

Development of a simple and inexpensive Dual-Chamber Syringe

Daniel Bar-Shalom

Daniel Bar-Shalom, Associate Professor, University of Copenhagen

  • Enabling direct Lyophilization in the device and sealing under vaccum
  • Air free filling of solvent and air-free dissolution of the API in the solvent
  • Comparison of COC against Glass
  • Simultaneous freeze drying of 2 or more APIs while keeping them separated
  • clock

    15:50

    Afternoon Tea

    clock

    16:10

    Laser Coding for Glass Syringes

    • Total visibility of the manufacturing process through batch record/ pedigree on item level
    • Preventing of mix-ups between production lots even of unlabeled containers
    • Method to support filling lines clearing after product change
    • Identifying a single item in the after sales supply chain to authenticate its original provenance to fight against product piracy

    Anil-Kumar Busimi

    Anil-Kumar Busimi, Product Manager, SCHOTT AG

    Sergej Toedtli

    Sergej Toedtli, CEO, Vesdo Ltd

    clock

    16:50

    Primary container developments; Glass V Plastic

    • Developments in glass syringes; stability and permeability
    • Advanced processing and inspections of glass containers
    • New manufacturing techniques of polymer based containers
    • Filling capability of polymer syringes

    Martin Bontoft

    Martin Bontoft, Head of Design Research, Team Consulting

    Patrick Garidel

    Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim Corporation

    Advait Badkar PhD.

    Advait Badkar PhD., Associate Research Fellow- Technology Lead, Pfizer Inc

    clock

    17:20

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Patrick Garidel

    Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim Corporation

    clock

    9:10

    The future of ampoules: are they superseded by pre-filled syringes for all drugs, even generics

    Dan Wheeler

    Dan Wheeler, Lecturer in Anaesthesia, University of Cambridge

    • Preparation of drugs at the bedside vs. pre-filled syringes
    • Problems with drug infusion on Intensive Care
    • Errors and delays during preparation of drug solutions

    clock

    9:50

    Secondary Packaging; Hero or villain of the PFS world? An overview to PFS Secondary Packaging machinery

    Dale Charlton

    Dale Charlton, Business Development Director, Optima Pharma

    • Relationship to filling lines
    • Current status of secondary packaging machinery
    • Current issues for the handling of filled syringes
    • Relationship to tertiary packaging

    clock

    10:20

    Morning Coffee

    clock

    10:50

    Validation and Qualification of a cRABS Clinical Supplies Line

    Mathias Misiek

    Mathias Misiek, Group Leader, Clinical Manufacturing, Roche Pharmaceuticals

    • Review of restricted access barrier systems
    • Obtaining a higher level of assurance for aseptic filling
    compared to cleanroom processes
    • Industrial scale production lines
    • Combination filling stations

    clock

    11:20

    Silicone layer control thickness and protein aggregation in pre-filled syringes

    Oliver K. Valet

    Oliver K. Valet, Managing director, rap.ID Particle Systems GmbH

    • Linking the influence of siliconisation parameters and the silicone agglomeration behaviour of the protein based drug
    • Enabling the understanding of the siliconization process in order to minimize silicone induced issues for development and manufacturing
    • Considering issues related to the interaction of silicone oil and protein based formulations
    • Investigating these interactions by image directed particle Raman spectroscopic analysis equipment (SPE)

    clock

    12:00

    The role of pre-filled syringes in patient safety

    David Whitaker

    David Whitaker, Consultant Anaesthetist, Manchester Royal Infirmary

    • Current trends in parenteral therapy
    • Intravenous medication safety
    • New international recommendations and regulations
    • Advantages of pre-filled syringes
    • Barriers to the introduction of pre-filled syringes

    clock

    12:35

    Networking Lunch

    clock

    13:50

    Safety Devices for Self-injection Drugs

    Alexander Jaksch

    Alexander Jaksch, VP Business Development & Marketing, Safety Syringes

    • Safety devices as a primary choice to be added to pre-filled syringes to meet anit-needlestick legislation around the globe
    • Currently a growing number of biotech drugs in pharma’s pipeline that require self-injection device to satisfy patients’ needs and handle new drug properties eg. Higher viscosities
    • How was the design of a clinically proven safety device adapted to meet those new requirements?

    clock

    14:30

    Reducing contamination and medical errors with PFS in the acute care environment and address the need for compatibility with syringe pumps

    Dragana Cvijanovic

    Dragana Cvijanovic, Product Manager, BD Medical - Pharmaceutical

    clock

    15:10

    Label-integrated needlestick prevention system for pre-filled syringes: A unique approach

    Frank Janssen

    Frank Janssen, Global Key Account Manager, Schreiner MediPharm

  • The caregivers’ and patients’ perspective – simple handling
  • The pharmaceutical companies’ perspective – easy processing
  • Environmental and supply chain impacts – minimized volume
  • Safety and reliability in healthcare practice – effective protection
  • clock

    15:50

    Afternoon Tea

    clock

    16:10

    Regulatory Aspects of Pre filled Syringes in Europe

    Morag Bratby

    Morag Bratby, Pharmaceutical Assessor, MHRA

    • Pre-filled syringe: medicinal product or medical device
    • Borderline Examples
    • Auto-injectors
    • Module 3: Quality - including special focus on the Manufacturing Process, Container Closure aspects
    • Agency feedback: Licensing
    • the Regulatory Horizon
    • Future MAA trends: Rapid Micro Methods

    clock

    16:40

    Pre-filled Syringes: An NHS Perspective

    Jasdeep Singh

    Jasdeep Singh, Head of PMU, Barts and the London NHS Trust

    • Manufacturing of pre-filled syringes as ‘specials’
    • Problems at the coal face – how can we overcome then?
    • Patient perspectives
    • Lessons pharma can learn from the NHS

    clock

    17:10

    Manufacturing pre-filled syringes with a contract manufacturing partner

    Richard  Hart

    Richard Hart, Pharma Partner Executive, Baxter

    • Finding and selecting a partner
    • Contracting for success
    • Overcoming challenges
    • Achieving excellent outcomes

    clock

    17:40

    Chairman’s Closing Remarks and Close of Day Two


    Associate Research Fellow- Technology Lead
    Pfizer Inc
    VP Business Development & Marketing
    Safety Syringes
    Product Manager
    SCHOTT AG
    Principal Scientist
    Novo Nordisk
    Business Development Director
    Optima Pharma
    Lecturer in Anaesthesia
    University of Cambridge
    Associate Professor
    University of Copenhagen
    Consultant Anaesthetist
    Manchester Royal Infirmary
    Product Manager
    BD Medical - Pharmaceutical
    Global Key Account Manager
    Schreiner MediPharm
    Head of PMU
    Barts and the London NHS Trust
    Head of Design Research
    Team Consulting
    Group Leader, Clinical Manufacturing
    Roche Pharmaceuticals
    Pharmaceutical Assessor
    MHRA
    Manager CZ European Business Development
    West Pharmaceutical Services
    Product Manager
    BD Medical - Pharmaceutical
    Managing director
    rap.ID Particle Systems GmbH
    Head of Pharmaceutical Basic Development
    Boehringer Ingelheim Corporation
    Pharma Partner Executive
    Baxter
    CEO
    Vesdo Ltd
    Senior Director, Toxicology and Operations
    Forest Laboratories
    Head Global Pharmaceutical & Device Development
    Sandoz

    Workshops

    Safety Issues within Pre-Filled Syringes

    Safety Issues within Pre-Filled Syringes

    Copthorne Tara Hotel
    30 January 2013
    London, United Kingdom

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.